Sign In
Buy CERT
$5.60
-0.0200 (-0.356%)
At Close: Jun 03, 2026
Certara Announces Proposed Public Offering of Common Stock
06:10am, Friday, 03'rd Sep 2021
PRINCETON, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its
Certara to Participate in Upcoming Investor Conferences
04:30pm, Tuesday, 31'st Aug 2021
PRINCETON, N.J., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in a fireside chat at the fo
Certara Inc's (CERT) CEO William Feehery on Q2 2021 Results - Earnings Call Transcript
04:26pm, Saturday, 07'th Aug 2021
Certara Inc's (CERT) CEO William Feehery on Q2 2021 Results - Earnings Call Transcript
Certara To Buy Compliance Software Provider For $310; Q2 Earnings Beat Expectations, Raises FY21 Guidance
08:11am, Friday, 06'th Aug 2021
Certara Inc (NASDAQ: CERT) has agreed to acquire Pinnacle 21 for $310 million in cash and stock. Pinnacle 21's software tools are used to validate compliance to the Clinical Data Interchange Sta
Certara Reports Second Quarter 2021 Financial Results
04:20pm, Thursday, 05'th Aug 2021
Raises full year 2021 guidance and announces deal to acquire Pinnacle 21 Raises full year 2021 guidance and announces deal to acquire Pinnacle 21
Certara to Acquire Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical Data
04:15pm, Thursday, 05'th Aug 2021
Transaction expected to be accretive to Certara's revenue, revenue growth and adjusted EBITDA margin Transaction expected to be accretive to Certara's revenue, revenue growth and adjusted EBITDA margi
Mubadala Invests in Global Biosimulation Leader Certara
05:03pm, Tuesday, 27'th Jul 2021
PRINCETON, N.J., July 27, 2021 (GLOBE NEWSWIRE) -- Certara (NASDAQ: CERT), a global leader in biosimulation, today announced that Mubadala Investment Company (Mubadala) has made an approximately $250
Certara's Vaccine Simulator™ Accurately Predicted Optimal Timing Between Doses for COVID-19
05:30pm, Friday, 23'rd Jul 2021
Clinical Study Confirms Quantitative Systems Pharmacology (QSP) Prediction, Showcasing the Power of Biosimulation Technology Clinical Study Confirms Quantitative Systems Pharmacology (QSP) Prediction,
Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board Members
04:30pm, Thursday, 15'th Jul 2021
PRINCETON, N.J., July 15, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the appointments of Nancy Killefer and Cynthia Collins to its board of directors, effectiv
Certara to Report Second Quarter 2021 Financial Results on August 5, 2021
04:30pm, Wednesday, 14'th Jul 2021
PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of 2021
Certara Announces Update of BaseCase Software, the Company's Value Communication Platform
08:00am, Thursday, 08'th Jul 2021
Major Release to Help Life Science Companies Maximize Go-to-Market Impact Major Release to Help Life Science Companies Maximize Go-to-Market Impact
The PMDA enters 8th consecutive year of using Certara's biosimulation software The PMDA enters 8th consecutive year of using Certara's biosimulation software
Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
08:00am, Thursday, 20'th May 2021
PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick, Ch
Expanded capabilities in company's Immunogenicity and Immuno-oncology QSP Simulators broaden applicability for addressing safety and efficacy challenges Expanded capabilities in company's Immunogenic
Certara, Inc. (CERT) CEO William Feehery on Q1 2021 Results - Earnings Call Transcript
04:45am, Sunday, 09'th May 2021
Certara, Inc. (CERT) CEO William Feehery on Q1 2021 Results - Earnings Call Transcript
